Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New immune checkpoint antibody AbGn-168H displays promising efficacy and is well tolerated

Nov. 12, 2020

Corbus reports post-hoc analyses of RESOLVE-1 study of lenabasum for systemic sclerosis

Nov. 11, 2020

Promising phase II data for deucravacitinib in active psoriatic arthritis

Nov. 11, 2020

First-in-human data for LNA-043 as treatment of knee osteoarthritis

Nov. 11, 2020

SHR-0302 displays dose-dependent effects in rheumatoid arthritis

Nov. 11, 2020

Active pipeline of potential new lupus therapies unfolding as ACR begins

Nov. 6, 2020

Macrophages metabolically support muscle

Nov. 5, 2020

Discovery of novel highly potent ghrelin receptor full agonists

Oct. 20, 2020

Phase II trial of GLPG-1972 in osteoarthritis does not meet primary objective

Oct. 16, 2020

Ono Pharmaceutical synthesizes bispecific antibodies targeting CD19 and PD-1

Oct. 16, 2020

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...